HF
ISEE

HRT Financial’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

HRT Financial’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-65,481
Closed -$1.17M – 3493
2022
Q3 		$1.17M Buy
+65,481
New +$859K 0.01% 819
2022
Q1 		– Sell
-146,419
Closed -$2.45M – 4115
2021
Q4 		$2.45M Buy
+146,419
New +$2.4M 0.01% 555
2021
Q2 		– Sell
-11,812
Closed -$72K – 3737
2021
Q1 		$72K Buy
+11,812
New +$71.7K ﹤0.01% 2497

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

HRT Financial's ISEE Position: Q4 2022 in Review

HRT Financial sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2022, closing a stake of 65,481 shares — an estimated $1.17M sold.

HRT Financial first reported a position in ISEE in Q1 2021 and held it in 3 quarters. The position peaked at $2.45M in Q4 2021. 225 funds tracked by Wall St. Rank hold ISEE as of Q4 2022.

  • HRT Financial reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • HRT Financial sold 65,481 IVERIC bio, Inc. Common Stock shares in Q4 2022, an estimated $1.17M.
  • HRT Financial first reported a position in IVERIC bio, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • HRT Financial's IVERIC bio, Inc. Common Stock position peaked at $2.45M in Q4 2021.
  • 225 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2022.

Based on HRT Financial's 13F filing for Q4 2022, filed 10 Feb 2023.